Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
•
General Internal Medicine
When is it appropriate to recommend a diverting colostomy for treatment of anal cancer or low lying rectal cancer?
Fecal incontinence can be one indication. What are others?
Answer from: Radiation Oncologist at Academic Institution
If there is bowel obstruction/ near obstruction, recto-vaginal or rectovesical fistula formation.
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
I would add inability to pass a colonoscope all the way to the cecum.
Sign in or Register to read more
2701
2705
Related Questions
What's your follow up protocol for a near complete response (nCR) in rectal patients considering non-operative management (NOM)?
Which patients, if any, treated according to PROSPECT for an early stage rectal cancer, would you offer surveillance if they achieved cCR after neoadjuvant chemotherapy?
Would you change treatment approach for rectal cancer with an associated intussusception?
How do you manage persistent rectal bleeding in the setting of rectal adenocarcinoma in a treatment-naive patient?
How would you plan a post-op, distal rectal adenocarcinoma s/p neo-adjuvant chemotherapy and APR with minimal treatment response?
When treating pancreatic body/tail lesions that result in significant dose spread to the spleen, what is your threshold to offer pneumococcal, hemophilus influenza, and meningococcal vaccines?
When treating a bulky squamous cell carcinoma of the anal canal, do you try to limit the dose to the external anal sphincter to any particular number to reduce the risk of chronic fecal incontinence?
What are your top takeaways from ASCO GI 2025?
Given the results of ESOPEC from ASCO 2024, for which patients with resectable esophageal adenocarcinoma would you favor neoadjuvant chemoradiation?
Would you consider chemo-RT for duodenal adenocarcinoma s/p resection with at least 1 cm positive margin in a patient with a history of Crohn's disease?